Blue Owl Capital Corp (OBDC)

Blue Owl Capital Cor seeks investment opportunities in middle market companies located in the United States with an EBITDA of USD 10 - 250 million and annual revenue of USD 50 million - 2.5 billion. The fund focuses on broad range of sectors including business services, healthcare services, pharma & healthcare technology, aerospace & defense, software & technology and manufacturing & industrials. it provides financing in the form of senior secured or unsecured loans, subordinated loans or mezzanine loans and a lesser extent, equity-related securities and warrants for growth, acquisitions, market or product expansion, re-financings and recapitalizations with an investment size ranging from $20 to $250 million and it also acts as a lead investor.

Address

399 PARK AVENUE

NEW YORK, NY 10022

Founded

2015

Number of Employees

-

Website

http://www.blueowlcapitalcorporation.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	-	-	-	-	-	$51,280	$2,604	-	$22,089	-	$25,324
Average Price	-	-	-	-	-	-	$12.52	$13.99	-	$12.27	-	$12.49
# Shares Purchased	-	-	-	-	-	-	4,096,546	186,150	-	1,800,607	-	2,027,768

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-	-	-	-	11.8%	0.1%	-	14.1%	-	12.1%
S&P 500 Return to Date	-	-	-	-	-	-	74.8%	31.7%	-	31.3%	-	45.9%
Excess Total Return	-	-	-	-	-	-	-63.0%	-31.6%	-	-17.2%	-	-33.8%
Quartile Rank
Percentile Rank	-	-	-	-	-	-	36%	45%	-	54%	-	50%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed

OAKTREE SPECIALTY LENDING CORP

IMPEL PHARMACEUTICALS INC